Adela Banu

629 total citations
7 papers, 457 citations indexed

About

Adela Banu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Adela Banu has authored 7 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 2 papers in Surgery. Recurrent topics in Adela Banu's work include Prostate Cancer Treatment and Research (4 papers), Prostate Cancer Diagnosis and Treatment (3 papers) and Cancer Genomics and Diagnostics (2 papers). Adela Banu is often cited by papers focused on Prostate Cancer Treatment and Research (4 papers), Prostate Cancer Diagnosis and Treatment (3 papers) and Cancer Genomics and Diagnostics (2 papers). Adela Banu collaborates with scholars based in France, Italy and Romania. Adela Banu's co-authors include Eugéniu Banu, Stéphane Oudard, Jean‐Marie Andrieu, Jacques Médioni, Florian Scotté, Dominique Helley, Anne‐Marie Fischer, Annick Vieillefond, Frédéric Rolland and Bernard Escudier and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Journal of Urology.

In The Last Decade

Adela Banu

7 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adela Banu France 7 270 199 179 120 66 7 457
Erjiang Tang China 10 117 0.4× 177 0.9× 58 0.3× 75 0.6× 55 0.8× 22 368
X. Tchiknavorian France 7 151 0.6× 270 1.4× 60 0.3× 98 0.8× 56 0.8× 13 362
J.T. Soper United States 9 112 0.4× 165 0.8× 72 0.4× 54 0.5× 98 1.5× 14 417
H. Franklin Netherlands 9 215 0.8× 416 2.1× 115 0.6× 55 0.5× 96 1.5× 11 535
Anne Favret United States 8 120 0.4× 272 1.4× 37 0.2× 132 1.1× 22 0.3× 16 365
Craig Vargo United States 8 102 0.4× 172 0.9× 114 0.6× 76 0.6× 19 0.3× 20 340
Hytham Al‐Masri United States 7 163 0.6× 284 1.4× 72 0.4× 62 0.5× 68 1.0× 14 396
G.F. Samelis Greece 10 159 0.6× 247 1.2× 54 0.3× 24 0.2× 121 1.8× 23 372
Youhua Jiang China 14 244 0.9× 220 1.1× 162 0.9× 149 1.2× 232 3.5× 40 551
F. Daniel United Kingdom 8 174 0.6× 232 1.2× 71 0.4× 93 0.8× 144 2.2× 13 374

Countries citing papers authored by Adela Banu

Since Specialization
Citations

This map shows the geographic impact of Adela Banu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adela Banu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adela Banu more than expected).

Fields of papers citing papers by Adela Banu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adela Banu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adela Banu. The network helps show where Adela Banu may publish in the future.

Co-authorship network of co-authors of Adela Banu

This figure shows the co-authorship network connecting the top 25 collaborators of Adela Banu. A scholar is included among the top collaborators of Adela Banu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adela Banu. Adela Banu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Oudard, Stéphane, Eugéniu Banu, Jacques Médioni, et al.. (2009). What is the real impact of bone pain on survival in patients with metastatic hormone‐refractory prostate cancer treated with docetaxel?. British Journal of Urology. 103(12). 1641–1646. 27 indexed citations
2.
Helley, Dominique, Eugéniu Banu, Adela Banu, et al.. (2008). Platelet Microparticles: A Potential Predictive Factor of Survival in Hormone-Refractory Prostate Cancer Patients Treated with Docetaxel-Based Chemotherapy. European Urology. 56(3). 479–485. 88 indexed citations
3.
Scotté, Florian, Eugéniu Banu, Jacques Médioni, et al.. (2008). Matched case‐control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel‐induced onycholysis and cutaneous toxicity of the foot. Cancer. 112(7). 1625–1631. 67 indexed citations
4.
Banu, Eugéniu, Adela Banu, Andrei Fodor, et al.. (2007). Meta-Analysis of Randomised Trials Comparing Gemcitabine-Based Doublets versus Gemcitabine Alone in Patients with Advanced and Metastatic Pancreatic Cancer. Drugs & Aging. 24(10). 865–879. 27 indexed citations
5.
Banu, Eugéniu, Adela Banu, Jacques Médioni, et al.. (2007). Serum PSA half‐life as a predictor of survival for hormone‐refractory prostate cancer patients: Modelization using a standardized set of response criteria. The Prostate. 67(14). 1543–1549. 10 indexed citations
6.
Oudard, Stéphane, Eugéniu Banu, Annick Vieillefond, et al.. (2007). Prospective Multicenter Phase II Study of Gemcitabine Plus Platinum Salt for Metastatic Collecting Duct Carcinoma: Results of a GETUG (Groupe d’Etudes des Tumeurs Uro-Génitales) Study. The Journal of Urology. 177(5). 1698–1702. 134 indexed citations
7.
Oudard, Stéphane, Eugéniu Banu, Philippe Beuzeboc, et al.. (2005). Multicenter Randomized Phase II Study of Two Schedules of Docetaxel, Estramustine, and Prednisone Versus Mitoxantrone Plus Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer. Journal of Clinical Oncology. 23(15). 3343–3351. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026